FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.8.2  |  FHIR Version n/a  User: [n/a]

126206004: Recombinant human insulin analog (substance)


    Status: retired, Not sufficiently defined by necessary conditions definition status (core metadata concept). Date: 31-Jan 2020. Module: SNOMED CT core

    Descriptions:

    Id Description Lang Type Status Case? Module
    34223017 Recombinant human insulin analog en Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT core
    473652010 Recombinant human insulin analogue en Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT core
    730139016 Recombinant human insulin analog (substance) en Fully specified name Active Entire term case insensitive (core metadata concept) SNOMED CT core
    3226831000005116 rekombinant human insulinanalog da Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) Danish module (core metadata concept)


    0 descendants.

    Expanded Value Set


    Outbound Relationships Type Target Active Characteristic Refinability Group Values
    rekombinant human insulinanalog Is a Human insulin false Inferred relationship Some
    rekombinant human insulinanalog Is a Recombinant protein (substance) false Inferred relationship Some
    rekombinant human insulinanalog This attribute specifies the behavior that a substance will exhibit or participate in, given the appropriate context. Pancreatic hormone (disposition) false Inferred relationship Some

    Inbound Relationships Type Active Source Characteristic Refinability Group
    Insulin glargine Is a False rekombinant human insulinanalog Inferred relationship Some
    rekombinant humant insulinanalogpræparat The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False rekombinant human insulinanalog Inferred relationship Some 1
    Product containing insulin glargine (medicinal product) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False rekombinant human insulinanalog Inferred relationship Some
    Insulin glargine 100u/mL injection solution vial The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False rekombinant human insulinanalog Inferred relationship Some
    insulin glargin (rekombinant humant insulinanalog) 100 enheder/ml injektionsvæske, opløsning, cylinderampul a 3 ml The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False rekombinant human insulinanalog Inferred relationship Some
    insulin glargin (rekombinant human insulinanalog) 100 enheder/ml injektionsvæske, hætteglas a 10 ml The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False rekombinant human insulinanalog Inferred relationship Some
    insulin glargin (rekombinant humant insulinanalog) 100 enheder/ml injektionsvæske, 3 ml fyldt injektionsudstyr til engangsbrug The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False rekombinant human insulinanalog Inferred relationship Some
    Insulin glargine 100iu/mL injection cartridge The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False rekombinant human insulinanalog Inferred relationship Some
    Insulin glargine 100iu/mL injection vial The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False rekombinant human insulinanalog Inferred relationship Some
    Insulin glargine 100iu/mL prefilled pen The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False rekombinant human insulinanalog Inferred relationship Some
    rekombinant human insulin NPH-analog Is a False rekombinant human insulinanalog Inferred relationship Some
    Recombinant human regular insulin (substance) Is a False rekombinant human insulinanalog Inferred relationship Some
    langtidsvirkende rekombinant humant zinkinsulin Is a False rekombinant human insulinanalog Inferred relationship Some
    Product containing insulin glulisine (medicinal product) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False rekombinant human insulinanalog Inferred relationship Some
    isofaninsulin NPH + rekombinant human insulin The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False rekombinant human insulinanalog Inferred relationship Some
    insulin glulisin 100 enheder/ml injektionsvæske, hætteglas a 10 ml The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False rekombinant human insulinanalog Inferred relationship Some
    Product containing insulin detemir (medicinal product) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False rekombinant human insulinanalog Inferred relationship Some
    Insulin detemir 100iu/mL prefilled pen The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False rekombinant human insulinanalog Inferred relationship Some
    Insulin detemir 100iu/mL injection cartridge The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False rekombinant human insulinanalog Inferred relationship Some
    insulin glulisin 100 IE/ml injektionsvæske, cylinderampul a 3 ml The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False rekombinant human insulinanalog Inferred relationship Some

    Reference Sets

    Concept inactivation indicator reference set

    POSSIBLY EQUIVALENT TO association reference set (foundation metadata concept)

    Back to Start